Skip to main content
SpringerLink
Log in

Pegloticase-related serious AEs reported at ACR meeting

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Savient Pharmaceuticals Inc.Savient’s Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference. Media Release: 27 Oct 2008. Available from: URL: http://www.savient.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pegloticase-related serious AEs reported at ACR meeting. React. Wkly. 1227, 2 (2008). https://doi.org/10.2165/00128415-200812270-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812270-00003

Keywords

Search

Navigation